GENVOR INCORPORATED Increase (Decrease) in Other Operating Liabilities
GENVOR INCORPORATED (GNVR) reported Increase (Decrease) in Other Operating Liabilities of $1.65 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-14
- GENVOR INCORPORATED increase (decrease) in other operating liabilities for the quarter ending 2023-09-30 was $0.00.
- GENVOR INCORPORATED increase (decrease) in other operating liabilities for the quarter ending 2023-06-30 was $0.00.
- GENVOR INCORPORATED increase (decrease) in other operating liabilities for the quarter ending 2023-03-31 was $0.00.
- GENVOR INCORPORATED increase (decrease) in other operating liabilities for the quarter ending 2022-12-31 was -$246.40K.
- GENVOR INCORPORATED increase (decrease) in other operating liabilities for fiscal 2023 was -$246.40K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.65M 10-Q · filed 2026-08-14 | |||
| 2023-09-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-09 | $0.00 derived: sum of 2 quarters · filed 2025-09-09 | $0.00 derived: sum of 3 quarters · filed 2025-09-09 | -$246.40K 10-K/A · filed 2025-09-09 |
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-30 | $0.00 derived: sum of 2 quarters · filed 2025-06-30 | -$246.40K 10-Q · filed 2025-06-30 | |
| 2023-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-13 | -$246.40K 10-Q · filed 2024-05-13 | ||
| 2022-12-31 | -$246.40K 10-Q · filed 2024-02-14 | |||
| 2022-06-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-01-16 | $2.80K 10-Q/A · filed 2024-01-16 | ||
| 2022-03-31 | $2.80K 10-Q/A · filed 2024-01-16 |